Introduction
============

Angioimmunoblastic T-cell lymphoma (AITL) is categorized as a peripheral T-cell lymphoma and is clinically characterized by a sudden onset of constitutional symptoms, lymphadenopathy, hepatosplenomegaly, immune disease (hyperactivity of the immune system and immunodeficiency) and pleural effusion, ascites, and edema [@b1]--[@b3]. Up to approximate half of patients have skin lesions but vesicles directly caused by AITL are rare [@b1],[@b3]--[@b5]. Elevated white blood cells (usually eosinophilia) are also often observed in laboratory investigations but to our knowledge, neutrophilic leukemoid reaction caused by AITL was not reported, yet [@b1]--[@b3],[@b6],[@b7].

Here, we present an AITL case presenting with rare skin lesions (including vesicles, papulovesicles, and miliary papules) symmetrically distributed on the extremities and trunk, with more distal lesions increasing in severity and neutrophilic leukemoid reaction.

Case Report
===========

A 53-year-old Asian man was referred to our hospital for evaluation of lymphadenopathy and skin lesions. The patient\'s symptom history was detailed as follows: a dry cough for 3 months, lymphadenopathy for 1 month, skin lesions (started from the extremities) accompanied by pruritus for 3 weeks, dyspnea, and a mild fever for 1 week. At the time of admittance to our hospital, the patient endured severe pain of vesicles on hands and feet. Upon examination, the skin lesions were symmetrically distributed, with more distal lesions increasing in severity. Some large vesicles containing dark reddish exudate were distributed on both fingers and feet (Fig.[1A](#fig01){ref-type="fig"} and [B](#fig01){ref-type="fig"}). Some vesicles (large and small) and papulovesicles containing clear transparent exudate were distributed on the extremities (Fig.[1A](#fig01){ref-type="fig"} and [C](#fig01){ref-type="fig"}). Miliary papules were distributed on the upper chest and lower abdomen. Few lesions were found in the face while skin lesions were not found in the palms, soles, genitalia, scalp, around the mouth, or oral mucosa. There were palpable superficial lymph nodes in the neck, axillary fossae, and inguinas. The temperature of the skin was between 37.0 and 38.5°C during his hospitalization. The routine blood test showed a white blood cell count of 44.43 × 10^9^/L, red blood cell count of 5.02 × 10^12^/L, and platelet count of 214 × 10^9^/L. The cytological study of bone marrow showed hypergranulopoiesis. A computed tomography scan of the chest revealed lymphadenopathy in the mediastinum and axillary fossae (Fig.[2A](#fig02){ref-type="fig"}--[C](#fig02){ref-type="fig"}). Immunochemistry of biopsy from cervical lymphadenopathy showed CD3 was diffuse strong positive, CD20 and CD8 was scattered positive, CD21 and Bcl-2 were focally positive, and Ki67 positive cells ratio was higher than 80%. Based on the cytological study of bone marrow, peripheral blood, immunochemistry and hematoxylin & eosin staining of lymphadenopathy (Fig.[2D](#fig02){ref-type="fig"}), the pathologic diagnosis was AITL.

![Skin lesions.](ccr30003-0483-f1){#fig01}

![Computed tomography (A--C) and hematoxylin & eosin staining of lymphadenopathy (D). Diffuse infiltration of immunoblasts, abnormal lymphoid cells, clear/pale cells, and proliferation of high endothelial venules are observed in hematoxylin & eosin staining of lymphadenopathy.](ccr30003-0483-f2){#fig02}

Both morphine and tramadol were used to control pain. After 4 days of intravenous latamoxef sodium and isepamicin treatment, the routine blood test showed a white blood cell count of 58.97 × 10^9^/L (neutrophils% 91.64%, lymphocytes% 5.24%, monocytes% 2.44%, and eosinophils% 0.42%), red blood cell count of 4.50 × 10^12^/L, and platelet count of 177 × 10^9^/L. Manifestations progressively aggravated. Then chemotherapy consisting of cyclophosphamide, epirubicin, vincristine, and prednisone (CHOP-like therapy) was administered. After chemotherapy, there was abatement of clinical manifestations. The number of skin lesions increased during his 9 days of hospitalization. Some vesicles were blisters in the beginning, without erythematous or hemorrhagic base. Some papules on extremities slowly became papulovesicles and it usually took 1 week. None of papules on the trunk became papulovesicles or vesicles. The patient abandoned further treatment.

Discussion
==========

AITL is a rare malignancy accounting for about 2% of all non-Hodgkin lymphoma and a highly aggressive neoplasm of the elderly [@b1]--[@b3],[@b8]. The median patients' age is approximate 65 years [@b1]--[@b3],[@b8],[@b9]. It generally presents with lymphadenopathy and is almost always accompanied by concomitant symptoms, including B symptoms, skin lesions, splenomegaly, hepatomegaly, effusion/edema/ascites, anemia, thrombocytopenia, elevated LDH, hypergammaglobulinemia and so on (Table[1](#tbl1){ref-type="table"}).

###### 

Clinical manifestations of AITL (numbers are presented as % except Patient number and Age)

  Authors                          Federico [@b1]   Tokunaga [@b2]   Mourad [@b3]   Lachenal [@b9]   Siegert [@b4]   Aozasa [@b25]
  -------------------------------- ---------------- ---------------- -------------- ---------------- --------------- ---------------
  Patient number                   243              207              157            77               62              44
  Age, years                                                                                                         
   Mean                            65               67               62             64.5             64              64
   Range                           20--86           34--91           20--89         30--91           21--87          25--84
  Male sex                         56               64                              56               58              55
  Lymphadenopathy                                                                                                    
   Generalized                     76                                               90                               84
   Localized                       24                                               9                                16
  Skin rash                        21                                44             45               49              27
  B symptoms                       69               60               72             77               68              
  Splenomegaly                     35                                               51                               39
  Hepatomegaly                     26                                               26                               52
  Effusion/edema/ascites                            14               26             25               \>38            
  Bone marrow involvement          28               29               47                                              
  Extranodal sites, \>1            27               23               46                                              
  Anemia                           33               61               65             51               57              20
  Platelet count \<150 × 10^9^/L   25               34                              20               20              
  Elevated LDH                     60               75               66             71               70              
  Elevated C-reactive protein      35               46                              67                               
  Hypergammaglobulinemia           30                                50             51               51              64
  Positive Coombs test             13               46               33             58               32              

LDH, Lactate dehydrogenase.

Nearly half of AITL patients have skin lesions [@b1],[@b3]--[@b5],[@b8]. Skin lesions can precede, follow or be concurrent to lymphadenopathy [@b5],[@b10],[@b11]. AITL skin lesions do not have characteristics to enable it to be distinguished from other skin eruptions, especially from drug eruptions. Therefore, misdiagnosis is not rare [@b5],[@b12]--[@b14]. Since AITL is almost always accompanied by concomitant symptoms (Table[1](#tbl1){ref-type="table"}), to be familiar with the common clinical characteristics and types of skin lesions is greatly helpful to avoid misdiagnosis.

Skin lesions in AITL usually accompany pruritus [@b1]--[@b5],[@b8]. Typical lesions are usually a generalized morbilliform or maculopapular eruptions on the trunk mimicking toxic erythema [@b2],[@b4],[@b5],[@b8]. In the literature, uncommon skin lesions of AITL are mostly described in case reports or review articles (Table[2](#tbl2){ref-type="table"}). It is not rare that the patient has a generalized pleomorphic rash composed of several types of rashes, such as macula, papules, maculopapules, nodules, erythroderma, urticaria, petechiae, purpura and so on. Necrotic purpura, polyarthritis, gingival ulceration, erythematous plaques (sometimes annular), toxic epidermal necrolysis, and hemorragic/necrotic nodules are also reported. Two cases of vesicles (one is pruritic papulovesicular (prurigo-like) lesion and the other is a pale erythematous eruption and violaceous plaques with bullae containing pale yellow exude.) were reported but they are apparently different from our case [@b5],[@b15].

###### 

Uncommon skin lesions of AITL

  Authors                Age/Gender   Skin lesions                                                                         Duration of skin lesions before/after onset of lymphadenopathy   Prognosis
  ---------------------- ------------ ------------------------------------------------------------------------------------ ---------------------------------------------------------------- ------------------
  Wechsler [@b29]        53/F         Erythematous macules; petechiae; purpura                                             1 month after                                                    Died (23 month)
  Matloff [@b30]         77/M         Macules; petechiae; purpura                                                          1 year before                                                    Alive (4 month)
  Seehafer [@b10]        74/M         Petechiae                                                                            Concurrent                                                       Died (3 month)
  Seehafer [@b10]        61/M         Erythroderma and purpura                                                             Concurrent                                                       Alive (48 month)
  Seehafer [@b10]        57/M         Petechiae                                                                            10 month before                                                  Alive (48 month)
  Schmuth [@b31]         73/F         Macules; petechiae; purpura                                                          4 week before                                                    Alive (4 month)
  Martel [@b15]                       Necrotic purpura, maculopapules and urticaria                                                                                                         Died (26 day)
  Martel [@b15]                       Pruritic papulovesicular (prurigo-like) lesion                                                                                                        Alive (96 month)
  Hashefi [@b32]                      Maculopapules, petechiae                                                             3 month before                                                   Died (23 month)
  Suarez-Vilela [@b33]   67/F         Sarcoidosis                                                                          1 month before                                                   
  Huang [@b34]           62//M        Erythroderma; plaques; nodules                                                       3 year after                                                     Died (3 year)
  Jones [@b35]           67/M         Erythroderma, toxic epidermal necrolysis                                             Concurrent                                                       Died (5 month)
  Tsochatzis [@b36]      50/M         Polyarthritis, subcutaneous nodules                                                  Concurrent                                                       Died (2 month)
  Jayaraman [@b11]       61/M         Macules, papules, plaques, and nodules                                               Concurrent                                                       Alive (5 year)
  Ortonne [@b37]         63/F         Nodules, gingival ulceration                                                                                                                          
  Ortonne [@b37]         54/M         Maculopapules, hemorragic/necrotic nodules                                                                                                            
  Nassar [@b5]           M/47         Erythematous eruption; violaceous plaques with bullae containing pale yellow exude   3 month before                                                   Alive (4 month)
  Smithberger [@b38]     79/F         Cutaneous tumors and ulcerated nodules                                               No lymphadenopathy                                               
  Ponciano [@b39]        36/M         Erythematous plaques, sometimes annular                                              5 year before                                                    Alive (2 year)

Vesicles caused by virus infection (such as HSV, VZV) in AITL patients were sporadically reported [@b12]--[@b14],[@b16],[@b17]. Five AITL patients with VZV infection were reported in the literature and are summarized in Table[3](#tbl3){ref-type="table"} [@b12]--[@b14],[@b16],[@b17]. The skin lesions of varicella appear on the trunk and face, and rapidly spread centrifugally to involve other areas of the body. Manifestations consist of maculopapules, vesicles, and scabs in varying stages of evolution. Skin rashes become papules within 12 h then become vesicles within 2 days. Over a very short period of time they scab. This rapid progression from stage to stage characterizes the clinical syndrome of varicella and enables it to be distinguished from certain other vesicular eruptions [@b12],[@b18],[@b19]. Each skin vesicle appears on an erythematous base and immunocompromised patients have more numerous lesions, often with a hemorrhagic base [@b18],[@b19]. Since lesions in this patient were not symptoms of herpes zoster because of distribution of lesions and were quite unlike varicella [@b12],[@b14],[@b16]--[@b19], lesions are more likely caused by AITL than VZV infection. Further laboratory investigations (assessing for the presence of Epstein--Barr virus infected B cells, VZV in the lesional tissue, pathological examination of the lesional tissue, serological test and so on) can confirm the diagnosis but regretfully, the patient abandoned them.

###### 

VZV infection in AITL patients

  Authors            Age/Gender   Skin lesions of AITL     Duration[1](#tf3-1){ref-type="table-fn"}   Manifestations of VZV infection                            Duration[2](#tf3-2){ref-type="table-fn"}   Prognosis
  ------------------ ------------ ------------------------ ------------------------------------------ ---------------------------------------------------------- ------------------------------------------ -----------------
  Kaneko [@b14]      49/F         Maculopapule             Concurrent                                 Disseminated herpes zoster                                 13 month                                   Died (15 month)
  Zelickson [@b16]   73/F         Hyperkeratotic papules   1 week after                               Hemorrhagic vesicles and bullae                            Concurrent                                 Alive (4 month)
  Boni [@b17]        81/M         Maculopapule             2 month before                             Unilateral necrotizing herpes zoster                       2.5 month                                  Died (16 month)
  Kanzaki [@b13]     67/M         No                       Not applied                                An pharyngeal wall ulcer[3](#tf3-3){ref-type="table-fn"}   Concurrent                                 Alive (18 week)
  Imafuku [@b12]     67/M         Maculopapule             40 day before                              Varicella                                                  1 month                                    Alive

Duration of skin lesions before/after onset of lymphadenopathy.

Duration of herpes zoster infection after onset of AITL.

Elevation of antibodies against HSV and VZV were observed in the patient but the ulcer was unlikely caused by VZV.

As mentioned before, hematological changes including anemia, lymphopenia, leukocytosis, neutrophilia, eosinophilia, and thrombocytopenia, are often observed on laboratory investigations but leukemoid reaction is rare. Several cases mimicking plasma cell leukemia and one case of eosinophilic leukemoid reaction were reported by computer-based searches in PUBMED [@b6],[@b7],[@b20]. The routine blood test of this case showed a white blood cell count of 58.97 × 10^9^/L (neutrophils% 91.64%, lymphocytes% 5.24%, monocytes% 2.44%, eosinophils% 0.42%). To the best of our knowledge, this is the first report of neutrophilic leukemoid reaction in AITL.

Treatments to AITL are similar to other noncutaneous peripheral T-cell lymphoma but results are often unsatisfactory. The majority of cases are treated with chemotherapy (CHOP, CHOEP, and CHOP followed by ICE, CHOP followed by IVE, dose-adjusted EPOCH and HyperCVAD are the first line chemotherapies), stem cell transplantation, radiotherapy, and molecular targeted therapy [@b3],[@b8],[@b21]. Folate antagonists (methotrexate, pralatrexate), purine analogs (fludarabine, azathioprine), prednisone, cyclosporine A, lenalidomide/thalidomide, interferon, and denileukin diftitox are reported to be effective in treating AITL [@b1],[@b8],[@b22]. Alemtuzumab and bortezomib are promising therapy options that have been explored recently and warrant [@b8],[@b22].

Though about two thirds of patients can achieve a complete remission, only half survive longer than 2 years [@b3],[@b8]. International prognostic index (based on age, stage, serum LDH, ECOG/Zubrod performance status, and extranodal site) and prognostic index for peripheral T-cell lymphoma (based on age, performance status, serum lactate dehydrogenase (LDH) levels, and bone marrow involvement) are widely accepted and used [@b2]. Skin rashes imply poor prognosis [@b4],[@b23],[@b24]. Other factors, such as male sex, B symptoms, edema, ascites, mediastinal lymphadenopathy, anemia, thrombocytopenia, lymphocytopenia, elevated white blood cell, decreased hemoglobin, elevated IgA levels, lymph node eosinophilia, the presence of clear and convoluted cells, high microvessel density measured in the microenvironment, higher ratio of M2 macrophages, failure to achieve complete remission, and drug exposure are reported to correlate with poor prognosis [@b2],[@b3],[@b23]--[@b28]. So far, due to limited data available, prognostic factors in AITL sometimes yield controversial results.
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